Featured
Status
Health Topics
Any CategoryPsychiatry and Psychology
-
- Anxiety Disorders 27
- Bipolar and Related Disorders 1
- Disruptive, Impulse Control, and Conduct Disorders 1
- Elimination Disorders 2
- Mood Disorders 19
- Neurocognitive Disorders 9
- Neurodevelopmental Disorders 18
- Personality Disorders 14
- Schizophrenia Spectrum and Other Psychotic Disorders 3
- Sexual Dysfunctions, Psychological 3
- Sleep Wake Disorders 6
- Somatoform Disorders 2
- Substance-Related Disorders 33
- Trauma and Stressor Related Disorders 9
Search Clinical Trials
Recruiting
Glutathione in Mild Cognitive Impairment (External Link)
Subjects with MCI will be recruited by written informed consent using forms approved by the Baylor IRB. Subjects will stop nonvitamin supplements for 4wks before screening labs (blood count, HbA1c, …
Baylor Role:
Lead Sponsor
Recruiting
Mycobiome Evaluation in Children With Autism & GI Symptoms (External Link)
This study's primary aim is to explore the potential differences in the gut mycobiome of children with autism spectrum disorder compared to otherwise healthy children. The secondary objective of this …
Baylor Role:
Collaborator
Completed
Entolimod, an Adjuvant for Vaccine Augmentation (External Link)
This is a single-blind (participants are blinded), pilot study with no therapeutic or diagnostic intent and limited drug exposure. The study will be conducted at Baylor College of Medicine in …
Baylor Role:
Lead Sponsor
Withdrawn
Safe Return and Disposal of Unused Opioids (External Link)
Participants identified by the PI and participating research staff/coordinators that will receive opioids following discharge will be approached. The participant information sheet will be provided to the parents/legal guardian and …
Baylor Role:
Lead Sponsor
Completed
Effect of Monochromatic Light on Incidence of Emergence Delirium in Children (External Link)
Emergence delirium/emergence agitation (ED/EA) is a behavioral phenomenon of unclear etiology consisting of short lived behavioral changes that can be both traumatic to families and pose a safety risk to …
Baylor Role:
Lead Sponsor
Completed
Study to Treat Major Depressive Disorder With a New Medication (External Link)
Depressive disorders are among the most disabling medical conditions worldwide and currently available treatments fall short of addressing this large public health burden. Dysfunction within the brain reward system is …
Baylor Role:
Collaborator
Withdrawn
Post Discharge Circadian Rhythms Post Adenotonsillectomy (External Link)
Wearable technology has tremendous advantages over current methods of assessing RTB activity in the post-discharge pediatric population after AT, which rely on quality of life (QOL) scales, caregiver and patient …
Baylor Role:
Lead Sponsor
Completed
Prefrontal Cortical Engagement Through Non-Invasive Brain Stimulation in Schizophrenia (External Link)
Cognitive deficits are a strong predictor of functional outcome in schizophrenia, yet poorly remediated by current treatments. Disturbances in dorsolateral prefrontal cortex (DLPFC) function underlie core impairments such as in …
Baylor Role:
Lead Sponsor
Completed
Efficacy of Audio Recorded Guided Imagery vs Deep Breathing Exercises on Functional Gastrointestinal Pain Disorders (External Link)
Children managed in primary care with a functional gastrointestinal pain disorder will be recruited and studied for this trial. After participants are deemed eligible, they will complete multiple questionnaires and …
Baylor Role:
Lead Sponsor
Terminated
Non-Invasive Direct Current Stimulation for Cognition in Schizophrenia (External Link)
Cognitive functions and EEG correlates will be thoroughly assessed in schizophrenia patients undergoing a tDCS treatment and compared with patients receiving a placebo stimulation. The treatment will involve 20 minutes …
Baylor Role:
Lead Sponsor